Bioavailability and costs of once-daily and twice-daily tacrolimus formulations in de novo kidney transplantation. [electronic resource]
Producer: 20191108Description: e13311 p. digitalISSN:- 1399-0012
- Biological Availability
- Cost-Benefit Analysis
- Delayed-Action Preparations
- Drug Administration Schedule
- Female
- Follow-Up Studies
- Glomerular Filtration Rate
- Graft Rejection -- drug therapy
- Graft Survival
- Humans
- Immunosuppressive Agents -- economics
- Kidney Failure, Chronic -- economics
- Kidney Function Tests
- Kidney Transplantation -- adverse effects
- Male
- Middle Aged
- Multicenter Studies as Topic
- Prognosis
- Prospective Studies
- Randomized Controlled Trials as Topic
- Retrospective Studies
- Risk Factors
- Tacrolimus -- economics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.